Salama Balume

Dynport Vaccine Company, Llc

$16,877,312

Attributed

$16,877,312

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $6.2M · FY2012–14

$10M$7.5M$5M$2.5M$0

'12

'13

'14

Funding mix

By agency

NIH$16,877,312 · 1

By mechanism

N01$16,877,312 · 1

Top collaborators

No co-investigators on record.

Most similar at Dynport Vaccine Company, Llc

Same institution · by research overlap

Graig Shockey$9,887,057
David Shumway$6,214,596
George Saviolakis$1,316,543
Casey Long$2,265,501
Preston Holley$300,000

Others in their field

Top investigators on “Investigation”

Sonia M Thomas · Research Triangle Institute$700,865,642
David Heimbrook · Leidos Biomedical Research, Inc.$681,473,477
David Divins · Consortium For Ocean Leadership, Inc$609,772,544
Tracy L Nolen · Research Triangle Institute$474,487,152
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$448,008,305
Judith S. Currier · University Of California Los Angeles$395,422,692

Research focus

InvestigationClinical Trials UnitInfectious Disease TreatmentPhase I Clinical TrialsNovel TherapeuticsTherapeutic AgentsClinical TrialsTuberculosisResearch InfrastructureResistanceEntamoeba HistolyticaBacterial VaginosisVaginitisCarbapenem ResistanceCommunicable DiseasesEnterobacteriaceaeFungusOffice Of Administrative ManagementSimplexvirusAntimicrobial Resistance